Azra AI, RevealDx announce partnership

AuntMinnie.com staff writers

May 20, 2026

Azra AI has entered into a partnership with RevealDx to integrate that company's RevealAI-Lung lung nodule characterization software into Azra AI's enterprise incidental findings and oncology workflow platform.

The partnership builds on Azra AI's recent acquisition of Thynk Health, which offers cancer screening and incidental findings management. The incorporation of RevealAI-Lung into Azra AI's platform will help clinicians identify and manage high-risk nodules and access oncology workflow automation, according to the two firms.

RevealAI-Lung, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), characterizes incidental lung nodules by generating a Malignancy Similarity Index score intended to help radiologists make more informed follow-up recommendations, RevealDx said. The software has been validated on over 1,500 patients, according to the firm.

Cropped secondary capture examples. These are illustrative and not intended to imply superiority or inferiority of any device. (A) Posteroanterior radiograph in a 46-year-old female patient. The device correctly identified a right lower lobe nodule projected below the right hemidiaphragm and hilar lymphadenopathy. (B) Posteroanterior radiograph in an 86-year-old female patient with a classic Golden S sign highly suggestive of cancer. Three devices did not identify any findings. (C) The output from one device for the same radiograph as in B. The device placed a contour around the area of abnormality but mislabeled it as segmental collapse, and there are no other elements in the output to raise suspicion of cancer. (D) Posteroanterior radiograph in a 60-year-old male patient -- a case of confirmed lung cancer that was not deemed visible in retrospect. The device identified multiple false-positive abnormalities. (E) Posteroanterior radiograph in a 77-year-old female patient with two right lower lobe nodules. The device mislabeled the abnormality as infection -- a diagnostic term that could incorrectly influence clinical management. (F) Posteroanterior radiograph in a 77-year-old female patient with a right hilar tumor. Most of the lungs have been labeled by the device, with excessive overlap of the abnormality that pragmatically represents an incorrect result. All annotations shown were produced by the devices. LL = lung lesion, LO = lung opacity, PO = pleural other, TBC = tuberculosis.

AI devices vary widely in lung cancer detection

May 19, 2026

GE HealthCare opens free AI training program

May 19, 2026

HOPPR launches mammography vision-language model

May 19, 2026

Overview of the study design, including data collection, radiomics model construction, and biologic interpretation. (A) The primary cohort for model development and evaluation in the training and internal test sets includes 168 patients with colorectal cancer (CRC) from center 1 (Fudan University Shanghai Cancer Center), whereas external testing was performed using data from 85 patients from centers 2 (Huashan Hospital, Fudan University) and 3 (Zhongshan Hospital, Fudan University). For model interpretation, RNA sequencing (RNA-seq) data from 18 patients with CRC in center 1 and single-cell data from 35 patients from the Gene Expression Omnibus (GEO) database are incorporated. Mismatch repair (MMR) protein expression, obtained from pathologic reports in electronic medical records (EMRs), was used to identify patients with consensus molecular subtype 1 (CMS1) CRC. Tissue microarrays (TMAs) from surgically obtained CRC tissues were analyzed for immunohistochemical staining of caudal-type homeobox 2 (CDX2), 5-hydroxytryptamine receptor 2B (HTR2B), FERM domain containing 6 (FRMD6), and zinc finger E-box binding homeobox 1 (ZEB1), and the results were subsequently entered into an online classification tool that assigned patients to CMS2, 3, or 4 subtypes. (B) Radiomics workflow for CMS4 prediction. Lesions were manually delineated on T2-weighted imaging (T2WI) and contrast-enhanced (CE) T1-weighted imaging (T1WI), followed by radiomics feature extraction. Feature selection and model development were performed in the training set using machine-learning algorithms with fivefold cross-validation for model selection, and the final model was evaluated in the internal and external test sets using receiver operating characteristic (ROC) curve analysis. (C) Transcriptomic interpretation workflow. Using the radiomics-predicted CMS4 classification, bulk RNA sequencing (RNA-seq) data were used to perform differential expression analysis between predicted CMS4 and non-CMS4 groups, followed by pathway enrichment analyses to assess biologic relevance. Public single-cell RNA sequencing data from the Gene Expression Omnibus database were then used for cell-type–level interrogation to support interpretation of the associated pathways.

MRI-based ML model shows promise in colorectal cancer subtyping

May 19, 2026

AI devices vary widely in lung cancer detection

Three devices helped detect more cancerous tumors, whereas the other four devices helped detect fewer tumors.

May 19, 2026

Cropped secondary capture examples. These are illustrative and not intended to imply superiority or inferiority of any device. (A) Posteroanterior radiograph in a 46-year-old female patient. The device correctly identified a right lower lobe nodule projected below the right hemidiaphragm and hilar lymphadenopathy. (B) Posteroanterior radiograph in an 86-year-old female patient with a classic Golden S sign highly suggestive of cancer. Three devices did not identify any findings. (C) The output from one device for the same radiograph as in B. The device placed a contour around the area of abnormality but mislabeled it as segmental collapse, and there are no other elements in the output to raise suspicion of cancer. (D) Posteroanterior radiograph in a 60-year-old male patient -- a case of confirmed lung cancer that was not deemed visible in retrospect. The device identified multiple false-positive abnormalities. (E) Posteroanterior radiograph in a 77-year-old female patient with two right lower lobe nodules. The device mislabeled the abnormality as infection -- a diagnostic term that could incorrectly influence clinical management. (F) Posteroanterior radiograph in a 77-year-old female patient with a right hilar tumor. Most of the lungs have been labeled by the device, with excessive overlap of the abnormality that pragmatically represents an incorrect result. All annotations shown were produced by the devices. LL = lung lesion, LO = lung opacity, PO = pleural other, TBC = tuberculosis.

GE HealthCare opens free AI training program

By AuntMinnie.com staff writers

The company is making more than 20 hours of AI education available at no cost through its HelloAI program.

May 19, 2026

HOPPR launches mammography vision-language model

By AuntMinnie.com staff writers

The model was trained on more than 200,000 mammography studies from multiple U.S. sites.

May 19, 2026

MRI-based ML model shows promise in colorectal cancer subtyping

By Amerigo Allegretto

A machine-learning model based on MRI radiomics achieved high performance in predicting colorectal cancer subtypes.

May 19, 2026

Overview of the study design, including data collection, radiomics model construction, and biologic interpretation. (A) The primary cohort for model development and evaluation in the training and internal test sets includes 168 patients with colorectal cancer (CRC) from center 1 (Fudan University Shanghai Cancer Center), whereas external testing was performed using data from 85 patients from centers 2 (Huashan Hospital, Fudan University) and 3 (Zhongshan Hospital, Fudan University). For model interpretation, RNA sequencing (RNA-seq) data from 18 patients with CRC in center 1 and single-cell data from 35 patients from the Gene Expression Omnibus (GEO) database are incorporated. Mismatch repair (MMR) protein expression, obtained from pathologic reports in electronic medical records (EMRs), was used to identify patients with consensus molecular subtype 1 (CMS1) CRC. Tissue microarrays (TMAs) from surgically obtained CRC tissues were analyzed for immunohistochemical staining of caudal-type homeobox 2 (CDX2), 5-hydroxytryptamine receptor 2B (HTR2B), FERM domain containing 6 (FRMD6), and zinc finger E-box binding homeobox 1 (ZEB1), and the results were subsequently entered into an online classification tool that assigned patients to CMS2, 3, or 4 subtypes. (B) Radiomics workflow for CMS4 prediction. Lesions were manually delineated on T2-weighted imaging (T2WI) and contrast-enhanced (CE) T1-weighted imaging (T1WI), followed by radiomics feature extraction. Feature selection and model development were performed in the training set using machine-learning algorithms with fivefold cross-validation for model selection, and the final model was evaluated in the internal and external test sets using receiver operating characteristic (ROC) curve analysis. (C) Transcriptomic interpretation workflow. Using the radiomics-predicted CMS4 classification, bulk RNA sequencing (RNA-seq) data were used to perform differential expression analysis between predicted CMS4 and non-CMS4 groups, followed by pathway enrichment analyses to assess biologic relevance. Public single-cell RNA sequencing data from the Gene Expression Omnibus database were then used for cell-type–level interrogation to support interpretation of the associated pathways.

Viz.ai launches pulmonary AI suite

By AuntMinnie.com staff writers

The suite integrates acute and chronic pulmonary workflows in a single platform.

May 14, 2026

ISMRM: Researchers highlight advancements in MRI foundation models

Standardization is key to effective large-scale studies.

May 14, 2026

OmniMRI in the context of reporting.

Brainomix, Boehringer expand pulmonary fibrosis imaging AI partnership

By AuntMinnie.com staff writers

Platform measures lung features associated with interstitial lung diseases (ILD).

May 12, 2026

Women's Imaging MinnieCast, Episode 8: New NCCN guidance on AI and breast cancer risk

By Amerigo Allegretto

Bethany Niell, MD, PhD, talks new guidance on breast cancer screening by the NCCN, which includes image-based AI risk assessment.

May 8, 2026

Minnie Cast Thumbnail (4) (1)

AMA CPT Editorial Panel pushes emerging imaging tools proposals

By AuntMinnie.com staff writers

Proposals for new AI malignancy risk score, quantitative CT tools deferred.

May 7, 2026

Imaging fellow tries vibe coding to solve radiology challenges

Vibe coding outside the radiology department led to exploring real-world use cases.

May 6, 2026

Kaustav Bera, MD, discussed the rise of the radiologist-developer with AuntMinnie. In June, Bera will complete an abdominal imaging fellowship at Case Western Reserve University and plans to continue as an abdominal imager at Case Western.

ACR, SIIM approve AI practice parameter, launch Assess-AI registry

By AuntMinnie.com staff writers

The ACR and SIIM have approved an AI practice parameter, and the ACR has launched the Assess-AI registry.

May 5, 2026

Artificial Intelligence Ai 400

MRI reveals how hidden muscle fat increases risk to heart, metabolism

By Kate Madden Yee

The results suggest that MRI exams could "augment traditional risk factor screening," researchers noted.

May 5, 2026

Page 1 of 408